Xcout Intel
KayoThera, Inc.
KayoThera, Inc. is an early-stage, preclinical therapeutics company headquartered in Seattle, Washington. The firm focuses on developing first-in-class, oral, small molecule treatments.
Subscribe to see KayoThera, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
KayoThera, Inc. at a glance
KayoThera, Inc. is a drug discovery company headquartered in United States. Its most recent funding round, Series A, raised $5.2M in July 2023. Xcout tracks 5 named people at KayoThera, Inc., including Thong Q. Le (President & CEO).
KayoThera, Inc. leadership
- Thong Q. LePresident & CEO
- Mark EspositoResearcher / Founder
- Yibin KangProfessor / Founder
- Bruce L A CarterChairman
- Paul SekhriBoard Member
KayoThera, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $5.2M | 3 named | |
| SEC Form D filing | $4M | — | |
| Series A | $10.5M | 1 named | |
| SEC Form D filing | $750,000 | — | |
| Seed | Undisclosed | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
KayoThera, Inc. competitors
A few of KayoThera, Inc.'s closest competitors — see the full list of competitors and alternatives →
Bonum Therapeutics, Inc. is a startup holding company operating in the therapeutics and drug pipeline sector in Washington, United States.
Promontory Therapeutics Inc. is a privately held, clinical-stage pharmaceutical company founded in 2010 and headquartered in New York, NY. The firm focuses on small molecule immunotherapy.
Prazer Therapeutics is a biotechnology company founded in 2019 and headquartered in Seoul, South Korea. The company focuses on developing orally available, brain-penetrating small molecule therapeutics utilizing targeted protein degradation technology for novel drug discovery.
Omniox, Inc. is an early-stage biopharmaceutical company located in San Francisco, California, focused on developing new medicines for hypoxic diseases.
Ensho Therapeutics, Inc. is a privately held, clinical-stage biopharmaceutical company focused on developing breakthrough oral therapies for patients. Founded in 2024, the company is based in Morris Plains, New Jersey.
Kainova Therapeutics, formerly known as Domain Therapeutics, is a clinical-stage biopharmaceutical company headquartered in Montreal, Quebec. The company drives a clinical pipeline of advanced GPCR-modulating therapies to address unmet medical needs.
Get KayoThera, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on KayoThera, Inc. in Xcout Intel
- 5 named people with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access